T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
MasTec
MTZ
$23.9B
| $2.96M | ﹤0.01% |
41,291
-582
| -1% | -$45.4K |
|
|
DENN
1502
DELISTED
Denny's
DENN
| $2.96M | ﹤0.01% |
340,814
-2,677,999
| -89% | -$29.6M |
|
1503
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $2.95M | ﹤0.01% |
29,058
| – | – |
|
1504
Gentex
GNTX
$5.03B
| $2.94M | ﹤0.01% |
105,241
-13,899
| -12% | -$404K |
|
|
SYNH
1505
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.93M | ﹤0.01% |
40,928
-2,009
| -5% | -$147K |
|
1506
Toyota
TM
$226B
| $2.91M | ﹤0.01% |
18,887
+1,102
| +6% | +$182K |
|
|
SWN
1507
DELISTED
Southwestern Energy Company
SWN
| $2.91M | ﹤0.01% |
465,386
+37,875
| +9% | +$293K |
|
|
BBLN
1508
DELISTED
Babylon Holdings Limited
BBLN
| $2.9M | ﹤0.01% |
+118,774
| New | +$5.18M |
|
1509
SEI Investments
SEIC
$12.8B
| $2.9M | ﹤0.01% |
53,726
+3,960
| +8% | +$223K |
|
|
MPT
1510
Medical Properties Trust
MPT
$2.5B
| $2.9M | ﹤0.01% |
189,923
+7,103
| +4% | +$128K |
|
1511
Zillow
Z
$7.82B
| $2.9M | ﹤0.01% |
91,166
+399
| +0.4% | +$16K |
|
1512
Avis
CAR
$4.87B
| $2.87M | ﹤0.01% |
19,512
-1,273
| -6% | -$279K |
|
|
EXE
1513
Expand Energy Corp
EXE
$21.9B
| $2.83M | ﹤0.01% |
34,849
+5,478
| +19% | +$495K |
|
1514
Antero Resources
AR
$11.5B
| $2.82M | ﹤0.01% |
91,933
+13,107
| +17% | +$479K |
|
1515
Cullen/Frost Bankers
CFR
$10.6B
| $2.81M | ﹤0.01% |
24,124
+540
| +2% | +$69K |
|
|
SAIL
1516
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.8M | ﹤0.01% |
44,656
-1,786
| -4% | -$110K |
|
1517
DT Midstream
DTM
$14B
| $2.79M | ﹤0.01% |
56,847
+4,211
| +8% | +$230K |
|
1518
Edgewise Therapeutics
EWTX
$4.8B
| $2.78M | ﹤0.01% |
349,223
-552
| -0.2% | -$4.17K |
|
1519
Jefferies Financial Group
JEF
$12.7B
| $2.76M | ﹤0.01% |
104,532
+5,691
| +6% | +$168K |
|
1520
nVent Electric
NVT
$27.7B
| $2.76M | ﹤0.01% |
88,048
+249
| +0.3% | +$8.49K |
|
|
STOR
1521
DELISTED
STORE Capital Corporation
STOR
| $2.75M | ﹤0.01% |
105,424
-7,060
| -6% | -$195K |
|
1522
Commerce Bancshares
CBSH
$8.64B
| $2.75M | ﹤0.01% |
50,832
+3,490
| +7% | +$196K |
|
1523
Prestige Consumer Healthcare
PBH
$2.43B
| $2.75M | ﹤0.01% |
46,692
-2,961
| -6% | -$163K |
|
1524
First Bancorp
FBP
$4.53B
| $2.7M | ﹤0.01% |
208,913
+112,176
| +116% | +$1.54M |
|
1525
STAG Industrial
STAG
$7.09B
| $2.68M | ﹤0.01% |
86,894
-5,668
| -6% | -$201K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.